{"protocolSection": {"identificationModule": {"nctId": "NCT00581048", "orgStudyIdInfo": {"id": "IRB#051158"}, "secondaryIdInfos": [{"id": "5K23HL080030-02", "type": "NIH", "link": "https://reporter.nih.gov/quickSearch/5K23HL080030-02"}], "organization": {"fullName": "Vanderbilt University Medical Center", "class": "OTHER"}, "briefTitle": "Study on the Role of Treatment With Vitamin E on Asthmatic Responses in Allergic Asthmatics", "officialTitle": "Oxidant Stress and Allergic Asthma"}, "statusModule": {"statusVerifiedDate": "2018-03", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2006-12"}, "primaryCompletionDateStruct": {"date": "2011-04", "type": "ACTUAL"}, "completionDateStruct": {"date": "2011-10", "type": "ACTUAL"}, "studyFirstSubmitDate": "2007-12-22", "studyFirstSubmitQcDate": "2007-12-22", "studyFirstPostDateStruct": {"date": "2007-12-27", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2018-01-10", "resultsFirstSubmitQcDate": "2018-01-10", "resultsFirstPostDateStruct": {"date": "2018-02-06", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2018-03-02", "lastUpdatePostDateStruct": {"date": "2018-03-29", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "PRINCIPAL_INVESTIGATOR", "investigatorFullName": "Ryszard T. Dworski", "investigatorTitle": "MD, PhD", "investigatorAffiliation": "Vanderbilt University"}, "leadSponsor": {"name": "Vanderbilt University", "class": "OTHER"}, "collaborators": [{"name": "National Heart, Lung, and Blood Institute (NHLBI)", "class": "NIH"}]}, "oversightModule": {"oversightHasDmc": true}, "descriptionModule": {"briefSummary": "Asthma is a common respiratory disease of unknown etiology which currently affects approximately 7.5 % of the adult population ( ). Asthma is an inflammatory disorder of the airways. Airway inflammation is evident not only in patients with fatal asthma but also in mild asthmatics ( ). Oxidant stress, defined as inadequately controlled generation of toxic reactive oxygen species (ROS) in the cells or tissues is a common feature of inflammation, and has also been documented in asthma ( , ). However, the current understanding of the relationship between the inflammation and the oxidant stress in asthmatic airways is poor. Does oxidant stress contribute to the expression of asthmatic phenotypes independently of inflammation? If so, could asthmatics benefit from supplementation of antioxidants? These questions have been nagging us since our laboratory provided credible evidence of oxidant injury in the airways of allergic asthmatics ( ). The purpose of our study is to more precisely determine 1/ the pathophysiologic role of oxidative stress, and 2/ usefulness of antioxidant therapy using vitamin E in allergic asthma."}, "conditionsModule": {"conditions": ["Allergic Asthma"], "keywords": ["Asthma", "Allergy", "Atopy", "Vitamin E", "GSTP1", "Oxidative stress"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "NA", "interventionModel": "SINGLE_GROUP", "primaryPurpose": "BASIC_SCIENCE", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 33, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Natural source d-\u03b1-tocopheryl acetate", "type": "EXPERIMENTAL", "description": "1500 units daily for 16 weeks", "interventionNames": ["Drug: Natural source d-\u03b1-tocopheryl acetate"]}], "interventions": [{"type": "DRUG", "name": "Natural source d-\u03b1-tocopheryl acetate", "description": "1500 units daily for 16 weeks", "armGroupLabels": ["Natural source d-\u03b1-tocopheryl acetate"], "otherNames": ["Vitamin E"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Effect of Natural-source d-\u03b1-tocopheryl Acetate on the Baseline and Allergen-induced Levels of F2-isoprostanes in the Bronchoalveolar Lavage Fluid (BAL)", "timeFrame": "At baseline to after 16-18 weeks of treatment with vitamin E daily"}], "secondaryOutcomes": [{"measure": "Effect of Treatment With Vitamin E on Airway Reactivity to Methacholine", "timeFrame": "At baseline and After 16-18 weeks of treatment with vitamin E"}, {"measure": "Allergen-provoked Concentrations of Th1 and Th2 Cytokines in BAL", "timeFrame": "baseline to after 16-18 weeks of treatment with vitamin E daily"}, {"measure": "Allergen-provoked Concentrations of Immunoglobulin E (IgE) in BAL", "timeFrame": "baseline to after 16-18 weeks of treatment with vitamin E daily"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Normal health status except for allergic asthma\n* Physician diagnosis of mild allergic asthma\n* Positive allergen skin tests to common aeroallergens\n\nExclusion Criteria:\n\n* Use of systemic or high doses of inhaled corticosteroids, \\>840 mcg of inhaled beclomethasone of its equivalent (as defined in the consensus report (6))\n* Past history of severe asthma (as defined in the consensus report (6))\n* History of asthma exacerbation within the past month\n* History of recent upper respiratory infection within the past month\n* Active immunotherapy for allergic diseases\n* Significant disease other than allergic asthma and allergic rhinitis, such as coronary disease, hypertension, renal failure, anemia, immunodeficiency, cancer, diabetes\n* Present or remote tobacco smoking\n* Use of Over The Counter drugs including acetaminophen and pseudoephedrine, herbs, or vitamins\n* Psychiatric illness that would make adherence to protocol difficult\n* Inability to give informed consent\n* Nursing or pregnant women\n* Woman planning to become pregnant during the study or not using adequate birth control methods (barrier or hormonal methods)\n* H/o sensitivity to tocopherol-derivatives or medications used during bronchoscopy\n* Inability to comply with the research protocol", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "maximumAge": "50 Years", "stdAges": ["ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Ryszard Dworski, MD", "affiliation": "Vanderbilt University", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Dep. of Medicine, Div. of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University", "city": "Nashville", "state": "Tennessee", "zip": "37232-2650", "country": "United States", "geoPoint": {"lat": 36.16589, "lon": -86.78444}}]}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "Natural Source d-\u03b1-tocopheryl Acetate", "description": "1500 units daily for 16 weeks\n\nNatural source d-\u03b1-tocopheryl acetate: 1500 units daily for 16 weeks"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "33"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "33"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Natural Source d-\u03b1-tocopheryl Acetate", "description": "1500 units daily for 16 weeks\n\nNatural source d-\u03b1-tocopheryl acetate: 1500 units daily for 16 weeks"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "33"}]}], "measures": [{"title": "Age, Categorical", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "<=18 years", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Between 18 and 65 years", "measurements": [{"groupId": "BG000", "value": "33"}]}, {"title": ">=65 years", "measurements": [{"groupId": "BG000", "value": "0"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "22"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "11"}]}]}]}, {"title": "Race (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "American Indian or Alaska Native", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Native Hawaiian or Other Pacific Islander", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Black or African American", "measurements": [{"groupId": "BG000", "value": "4"}]}, {"title": "White", "measurements": [{"groupId": "BG000", "value": "29"}]}, {"title": "More than one race", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "0"}]}]}]}, {"title": "Region of Enrollment", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "United States", "categories": [{"measurements": [{"groupId": "BG000", "value": "33"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Effect of Natural-source d-\u03b1-tocopheryl Acetate on the Baseline and Allergen-induced Levels of F2-isoprostanes in the Bronchoalveolar Lavage Fluid (BAL)", "populationDescription": "Underlying data was lost. Go to https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476459 Figure 1 for diagram of results", "reportingStatus": "POSTED", "timeFrame": "At baseline to after 16-18 weeks of treatment with vitamin E daily", "groups": [{"id": "OG000", "title": "Before Treatment, Baseline"}, {"id": "OG001", "title": "After Treatment"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}, {"type": "SECONDARY", "title": "Effect of Treatment With Vitamin E on Airway Reactivity to Methacholine", "populationDescription": "Underlying data was lost. Go to https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476459 Figure 2 for diagram of results", "reportingStatus": "POSTED", "timeFrame": "At baseline and After 16-18 weeks of treatment with vitamin E", "groups": [{"id": "OG000", "title": "Before Treatment, Baseline"}, {"id": "OG001", "title": "After Treatment"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}, {"type": "SECONDARY", "title": "Allergen-provoked Concentrations of Th1 and Th2 Cytokines in BAL", "reportingStatus": "POSTED", "paramType": "MEDIAN", "dispersionType": "Inter-Quartile Range", "unitOfMeasure": "pg/mL", "timeFrame": "baseline to after 16-18 weeks of treatment with vitamin E daily", "groups": [{"id": "OG000", "title": "Before Treatment, Baseline"}, {"id": "OG001", "title": "After Treatment"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "33"}, {"groupId": "OG001", "value": "33"}]}], "classes": [{"title": "IL-1B", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.97", "lowerLimit": "0.3", "upperLimit": "1.69"}, {"groupId": "OG001", "value": "1.21", "lowerLimit": "0.52", "upperLimit": "1.98"}]}]}, {"title": "IL-2", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.48", "lowerLimit": "0.2", "upperLimit": "0.99"}, {"groupId": "OG001", "value": "0.69", "lowerLimit": "0.23", "upperLimit": "1.48"}]}]}, {"title": "IL-3", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.6", "lowerLimit": "0", "upperLimit": "7.7"}, {"groupId": "OG001", "value": "1.4", "lowerLimit": "0", "upperLimit": "4.5"}]}]}, {"title": "IL-4", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.17", "lowerLimit": "0.03", "upperLimit": "0.57"}, {"groupId": "OG001", "value": "0.045", "lowerLimit": "0", "upperLimit": "0.2"}]}]}, {"title": "IL-5", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.0", "lowerLimit": "0.33", "upperLimit": "2.9"}, {"groupId": "OG001", "value": "0.8", "lowerLimit": "0.41", "upperLimit": "13.6"}]}]}, {"title": "IL-6", "categories": [{"measurements": [{"groupId": "OG000", "value": "21.5", "lowerLimit": "5.55", "upperLimit": "111.9"}, {"groupId": "OG001", "value": "17", "lowerLimit": "4.35", "upperLimit": "94.6"}]}]}, {"title": "IL-9", "categories": [{"measurements": [{"groupId": "OG000", "value": "0", "lowerLimit": "0", "upperLimit": "6.25"}, {"groupId": "OG001", "value": "0", "lowerLimit": "0", "upperLimit": "5.6"}]}]}, {"title": "IL-10", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.53", "lowerLimit": "0.29", "upperLimit": "1.09"}, {"groupId": "OG001", "value": "0.7", "lowerLimit": "0.25", "upperLimit": "1.18"}]}]}, {"title": "IL-12", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.05", "lowerLimit": "0.002", "upperLimit": "0.21"}, {"groupId": "OG001", "value": "0.165", "lowerLimit": "0.078", "upperLimit": "0.41"}]}]}, {"title": "IL-13", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.6", "lowerLimit": "0.4", "upperLimit": "1.96"}, {"groupId": "OG001", "value": "1.0", "lowerLimit": "0.075", "upperLimit": "3.6"}]}]}, {"title": "TNF-a", "categories": [{"measurements": [{"groupId": "OG000", "value": "2.76", "lowerLimit": "0.65", "upperLimit": "11.6"}, {"groupId": "OG001", "value": "3.02", "lowerLimit": "0.96", "upperLimit": "14.3"}]}]}, {"title": "INF-Y", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.49", "lowerLimit": "0.23", "upperLimit": "0.96"}, {"groupId": "OG001", "value": "0.7", "lowerLimit": "0.3", "upperLimit": "1.65"}]}]}, {"title": "CXCL8", "categories": [{"measurements": [{"groupId": "OG000", "value": "44.0", "lowerLimit": "25.2", "upperLimit": "93.5"}, {"groupId": "OG001", "value": "53.2", "lowerLimit": "31.0", "upperLimit": "92.3"}]}]}, {"title": "CCL5", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.0", "lowerLimit": "1.36", "upperLimit": "7.11"}, {"groupId": "OG001", "value": "2.3", "lowerLimit": "1.71", "upperLimit": "8.34"}]}]}, {"title": "CCL11", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.0", "lowerLimit": "0", "upperLimit": "4.02"}, {"groupId": "OG001", "value": "2.70", "lowerLimit": "0", "upperLimit": "5.45"}]}]}]}, {"type": "SECONDARY", "title": "Allergen-provoked Concentrations of Immunoglobulin E (IgE) in BAL", "reportingStatus": "POSTED", "paramType": "MEDIAN", "dispersionType": "Inter-Quartile Range", "unitOfMeasure": "UI/ml", "timeFrame": "baseline to after 16-18 weeks of treatment with vitamin E daily", "groups": [{"id": "OG000", "title": "Before Treatment, Baseline"}, {"id": "OG001", "title": "After Treatment"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "33"}, {"groupId": "OG001", "value": "33"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "4.05", "lowerLimit": "2.81", "upperLimit": "10.8"}, {"groupId": "OG001", "value": "3.65", "lowerLimit": "2.87", "upperLimit": "12.9"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "eventGroups": [{"id": "EG000", "title": "Natural Source d-\u03b1-tocopheryl Acetate", "description": "1500 units daily for 16 weeks\n\nNatural source d-\u03b1-tocopheryl acetate: 1500 units daily for 16 weeks", "deathsNumAffected": 0, "deathsNumAtRisk": 33, "seriousNumAffected": 0, "seriousNumAtRisk": 33, "otherNumAffected": 0, "otherNumAtRisk": 33}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": true}, "pointOfContact": {"title": "Ryszard Dworski", "organization": "Vanderbilt University Medical Center", "email": "ryszard.dworski@Vanderbilt.Edu", "phone": "615-322-3412"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC20", "name": "Immune System Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000014810", "term": "Vitamin E"}, {"id": "D000024505", "term": "Tocopherols"}, {"id": "D000024502", "term": "alpha-Tocopherol"}], "ancestors": [{"id": "D000014815", "term": "Vitamins"}, {"id": "D000018977", "term": "Micronutrients"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000000975", "term": "Antioxidants"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}, {"id": "D000020011", "term": "Protective Agents"}], "browseLeaves": [{"id": "M17558", "name": "Vitamins", "relevance": "LOW"}, {"id": "M22972", "name": "Tocopherols", "asFound": "Attenuation correction", "relevance": "HIGH"}, {"id": "M17553", "name": "Vitamin E", "asFound": "Citrate", "relevance": "HIGH"}, {"id": "M22975", "name": "Tocotrienols", "relevance": "LOW"}, {"id": "M22969", "name": "alpha-Tocopherol", "asFound": "Attenuation correction", "relevance": "HIGH"}, {"id": "M21009", "name": "Micronutrients", "relevance": "LOW"}, {"id": "M16885", "name": "Trace Elements", "relevance": "LOW"}, {"id": "M4292", "name": "Antioxidants", "relevance": "LOW"}, {"id": "M21869", "name": "Protective Agents", "relevance": "LOW"}, {"id": "T466", "name": "Tocopherol", "asFound": "Attenuation correction", "relevance": "HIGH"}, {"id": "T467", "name": "Tocotrienol", "relevance": "LOW"}, {"id": "T480", "name": "Vitamin E", "asFound": "Citrate", "relevance": "HIGH"}], "browseBranches": [{"abbrev": "Micro", "name": "Micronutrients"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}, {"abbrev": "Vi", "name": "Vitamins"}]}}, "hasResults": true}